Pharming Group (OTCMKTS:PHGUF – Get Free Report) shares hit a new 52-week low on Tuesday . The company traded as low as $1.07 and last traded at $1.07, with a volume of 0 shares trading hands. The stock had previously closed at $1.07.
Pharming Group Trading Down 10.8 %
The company has a debt-to-equity ratio of 0.76, a quick ratio of 3.33 and a current ratio of 4.06. The firm has a fifty day moving average price of $1.17 and a two-hundred day moving average price of $1.17.
Pharming Group Company Profile
Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company's commercialized product is RUCONEST, a plasma-free rhC1INH protein replacement therapy for the treatment acute hereditary angioedema (HAE) attacks.
Recommended Stories
- Five stocks we like better than Pharming Group
- What is a Death Cross in Stocks?
- Comprehensive PepsiCo Stock Analysis
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- CSX Co.: The Railroad Powering Ahead with an Earnings Beat
- Financial Services Stocks Investing
- Bear Market Funds to Watch This Year
Receive News & Ratings for Pharming Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharming Group and related companies with MarketBeat.com's FREE daily email newsletter.
